Tissue Sparing Therapy of Female Precancerous Genital Lesions With VITOM
- Conditions
- Cervical Preinvasive Disease
- Interventions
- Device: ColposcopyDevice: Vitom
- Registration Number
- NCT01601769
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
Object of the study is the evaluation of the use of a rigid laparoscope for the diagnosis and therapy of lesions of the female genital tract as a substitution or a complementary method to colposcopy with the development of new standards for a tissue sparing therapy Use of existing laparoscopic instruments, which allow a better quality level in the diagnosis and therapy than the current routine.
Development of new optics and instruments, which allow a tissue sparing approach Pre and postoperative measurement of the cervical volume, to be sure that the tissue removal is kept to a minimum level Development of qualitaty parameters for the most tissue respecting operations of the uterine cervix Prospective evaluation of the influence of tissue sparing surgery on future pregnancies
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 300
- Karnowsky-Index > 80,
- 18-80 years,
- CIN.
- Pregnancy,
- Previous or current cancer,
- Radio therapy of the pelvis,
- Serious internistic accompanying diseases,
- Psychiatric diseases,
- HIV infection,
- Drug addiction.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Colposcopy Colposcopy a Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter. Vitom Vitom The VITOM system, consisting of the VITOM scope, xenon light source, HD camera system, AIDA HD documentation system, 1 monitor, and a mechanical support arm (all Karl Storz, Tuttlingen, Germany) is used for video exocolposcopy.
- Primary Outcome Measures
Name Time Method Cervical volume removed İmmediately after surgery Cervical volume removed during the operation is recorded
İntraoperative Complications During the intraoperative Complications encountered during the prodecure
Short term complications Within 48 hours after operation Complications within 48 hours after operation
Late complications After 48 hours Complications occuring after 48 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Charité University Hospital
🇩🇪Berlin, Germany